These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20009283)

  • 21. Frequency of isolation of various subtypes and antimicrobial resistance of Shigella from urban slums of Karachi, Pakistan.
    Zafar A; Hasan R; Nizami SQ; von Seidlein L; Soofi S; Ahsan T; Chandio S; Habib A; Bhutto N; Siddiqui FJ; Rizvi A; Clemens JD; Bhutta ZA
    Int J Infect Dis; 2009 Nov; 13(6):668-72. PubMed ID: 19135399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and antimicrobial susceptibility of Salmonella and Shigella spp. among children with gastroenteritis in an Iranian referral hospital.
    Mahmoudi S; Pourakbari B; Moradzadeh M; Eshaghi H; Ramezani A; Haghi Ashtiani MT; Keshavarz Valian S; Mamishi S
    Microb Pathog; 2017 Aug; 109():45-48. PubMed ID: 28526638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shigella isolates of Nepal: changes in the incidence of shigella subgroups and trends of antimicrobial susceptibility pattern.
    Kansakar P; Malla S; Ghimire GR
    Kathmandu Univ Med J (KUMJ); 2007; 5(1):32-7. PubMed ID: 18603983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Shigella serotypes and drug resistance patterns of strains isolated in Etimesgut, Turkey, in 1987].
    Korten V; Mert A; Ovünç K; Ceyhan M; Acar S; Ulaş T
    Mikrobiyol Bul; 1988 Apr; 22(2):89-94. PubMed ID: 3078794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial resistance trends of Shigella serotypes in New York City, 2006-2009.
    Wong MR; Reddy V; Hanson H; Johnson KM; Tsoi B; Cokes C; Gallagher L; Lee L; Plentsova A; Dang T; Krueger A; Joyce K; Balter S
    Microb Drug Resist; 2010 Jun; 16(2):155-61. PubMed ID: 20438349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial resistance of Shigella spp. from humans in Shanghai, China, 2004-2011.
    Zhang J; Jin H; Hu J; Yuan Z; Shi W; Yang X; Xu X; Meng J
    Diagn Microbiol Infect Dis; 2014 Mar; 78(3):282-6. PubMed ID: 24387959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing trends in the prevalence of Shigella species: emergence of multi-drug resistant Shigella sonnei biotype g in Bangladesh.
    Ud-Din AI; Wahid SU; Latif HA; Shahnaij M; Akter M; Azmi IJ; Hasan TN; Ahmed D; Hossain MA; Faruque AS; Faruque SM; Talukder KA
    PLoS One; 2013; 8(12):e82601. PubMed ID: 24367527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility of Shigella isolates in eight Asian countries, 2001-2004.
    Kuo CY; Su LH; Perera J; Carlos C; Tan BH; Kumarasinghe G; So T; Van PH; Chongthaleong A; Song JH; Chiu CH
    J Microbiol Immunol Infect; 2008 Apr; 41(2):107-11. PubMed ID: 18473096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, streptomycin, chloramphenicol, and tetracycline isolated from patients with shigellosis in northeastern Brazil during the period 1988 to 1993.
    Lima AA; Lima NL; Pinho MC; Barros Juñior EA; Teixeira MJ; Martins MC; Guerrant RL
    Antimicrob Agents Chemother; 1995 Jan; 39(1):256-9. PubMed ID: 7695319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug resistance of Shigella strains isolated in Ankara, Turkey, 1993-1996.
    Aysev AD; Guriz H
    Scand J Infect Dis; 1998; 30(4):351-3. PubMed ID: 9817513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial-resistant Shigella sonnei: limited antimicrobial treatment options for children and challenges of interpreting in vitro azithromycin susceptibility.
    Jain SK; Gupta A; Glanz B; Dick J; Siberry GK
    Pediatr Infect Dis J; 2005 Jun; 24(6):494-7. PubMed ID: 15933557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of drug-resistant Shigella infections.
    Klontz KC; Singh N
    Expert Rev Anti Infect Ther; 2015 Jan; 13(1):69-80. PubMed ID: 25399653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission risk factors and treatment of pediatric shigellosis during a large daycare center-associated outbreak of multidrug resistant Shigella sonnei: implications for the management of shigellosis outbreaks among children.
    Arvelo W; Hinkle CJ; Nguyen TA; Weiser T; Steinmuller N; Khan F; Gladbach S; Parsons M; Jennings D; Zhu BP; Mintz E; Bowen A
    Pediatr Infect Dis J; 2009 Nov; 28(11):976-80. PubMed ID: 19738503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serogroup prevalence of Shigellae in Bombay.
    Sonawala M; Saraswathi K; Deodhar LP
    J Postgrad Med; 1995; 41(4):104-6. PubMed ID: 10707731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virulence factors and mechanisms of antimicrobial resistance in Shigella strains from periurban areas of Lima (Peru).
    Lluque A; Mosquito S; Gomes C; Riveros M; Durand D; Tilley DH; Bernal M; Prada A; Ochoa TJ; Ruiz J
    Int J Med Microbiol; 2015; 305(4-5):480-90. PubMed ID: 25998616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and antimicrobial susceptibility patterns of Shigella species in Asmara, Eritrea, northeast Africa.
    Naik DG
    J Microbiol Immunol Infect; 2006 Oct; 39(5):392-5. PubMed ID: 17066201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing incidence of antibiotic resistance in shigellas from humans in England and Wales: recommendations for therapy.
    Cheasty T; Skinner JA; Rowe B; Threlfall EJ
    Microb Drug Resist; 1998; 4(1):57-60. PubMed ID: 9533726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin.
    Rahman M; Shoma S; Rashid H; El Arifeen S; Baqui AH; Siddique AK; Nair GB; Sack DA
    J Health Popul Nutr; 2007 Jun; 25(2):158-67. PubMed ID: 17985817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shigella Antimicrobial Drug Resistance Mechanisms, 2004-2014.
    Nüesch-Inderbinen M; Heini N; Zurfluh K; Althaus D; Hächler H; Stephan R
    Emerg Infect Dis; 2016 Jun; 22(6):1083-5. PubMed ID: 27191035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
    Cheasty T; Day M; Threlfall EJ
    Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.